Empire Financial Management Company’s Rigel Pharmaceuticals RIGL Stock Holding History

Empire Financial Management Company’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.23M	Sell	45,445 -31,000	-41%	-$1.04M	0.28%	98
2025 Q4	$3.27M	Sell	76,445 -13,066	-15%	-$493K	0.71%	50
2025 Q3	$2.54M	Buy	89,511 +66,011	+281%	+$1.97M	0.58%	57
2025 Q2	$440K	Hold	23,500	–	–	0.13%	151
2025 Q1	$423K	Buy	23,500 +11,500	+96%	+$233K	0.13%	149
2024 Q4	$202K	Sell	12,000 -2,250	-16%	-$43.2K	0.06%	195
2024 Q3	$231K	Buy	+14,250	New	+$168K	0.07%	188
2024 Q2	–	Sell	-30,450	Closed	-$451K	–	215
2024 Q1	$451K	Buy	30,450 +11,150	+58%	+$150K	0.15%	147
2023 Q4	$280K	Buy	+19,300	New	+$197K	0.11%	169

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Empire Financial Management Company's RIGL Position: Q1 2026 in Review

Empire Financial Management Company reduced its Rigel Pharmaceuticals (RIGL) stake by 41% in Q1 2026, selling an estimated $1.04M and leaving 45,445 shares worth $1.23M. The position accounts for 0.28% of the portfolio, ranked #98.

Empire Financial Management Company first reported a position in RIGL in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.27M in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

Empire Financial Management Company held 45,445 shares of Rigel Pharmaceuticals worth $1.23M as of Q1 2026.
Empire Financial Management Company sold 31,000 Rigel Pharmaceuticals shares in Q1 2026, an estimated $1.04M.
Rigel Pharmaceuticals made up 0.28% of Empire Financial Management Company's portfolio in Q1 2026, its #98 holding.
Empire Financial Management Company first reported a position in Rigel Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
Empire Financial Management Company's Rigel Pharmaceuticals position peaked at $3.27M in Q4 2025.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.